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Abstract
The Roadmap for Mental Health and Wellbeing Research in Europe (ROAMER) identified child and adolescent mental 
illness as a priority area for research. CAPICE (Childhood and Adolescence Psychopathology: unravelling the complex 
etiology by a large Interdisciplinary Collaboration in Europe) is a European Union (EU) funded training network aimed at 
investigating the causes of individual differences in common childhood and adolescent psychopathology, especially depres-
sion, anxiety, and attention deficit hyperactivity disorder. CAPICE brings together eight birth and childhood cohorts as well 
as other cohorts from the EArly Genetics and Life course Epidemiology (EAGLE) consortium, including twin cohorts, with 
unique longitudinal data on environmental exposures and mental health problems, and genetic data on participants. Here we 
describe the objectives, summarize the methodological approaches and initial results, and present the dissemination strategy 
of the CAPICE network. Besides identifying genetic and epigenetic variants associated with these phenotypes, analyses 
have been performed to shed light on the role of genetic factors and the interplay with the environment in influencing the 
persistence of symptoms across the lifespan. Data harmonization and building an advanced data catalogue are also part of 
the work plan. Findings will be disseminated to non-academic parties, in close collaboration with the Global Alliance of 
Mental Illness Advocacy Networks-Europe (GAMIAN-Europe).
Keywords Childhood and adolescence psychopathology · Depression · Anxiety · Attention deficit hyperactivity disorder 
(ADHD) · Psychiatric genetics
Introduction
The 2011 Roadmap for Mental Health and Wellbeing 
Research in Europe (ROAMER) [1–3] outlined six priorities 
for research in mental health, of which three are the focus of 
the EU funded Marie Skłodowska-Curie International Train-
ing Network CAPICE project: Childhood and Adolescence 
Psychopathology: unravelling the complex etiology by a 
large Interdisciplinary Collaboration in Europe:
(1) Research into prevention, mental health promotion, 
and interventions in children, adolescents, and young 
adults;
(2) Focus on the development and causal mechanisms of 
mental health symptoms, syndromes, and wellbeing 
across the lifespan (including older populations);
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(3) Develop and maintain international and interdiscipli-
nary research networks and shared databases in the area 
of childhood and adolescence psychopathology.
To address these priorities, CAPICE brings together data 
from eight population-based birth and childhood cohorts, 
including twin cohorts, to focus on the causes of individual 
differences in childhood and adolescent psychopathology 
and its course (see Tables 1, 2). The CAPICE cohorts have 
collected longitudinal data on behavioral and emotional 
symptoms, lifestyle characteristics and environmental meas-
ures as well as genetic and epigenetic data (see Table 2), 
some also from parents. Data from other cohorts from the 
EArly Genetics and Life course Epidemiology (EAGLE) 
consortium [4], behaviour and cognition group, can also be 
involved in the studies, especially for genome-wide asso-
ciation meta-analysis (GWAMA). The EAGLE consortium 
is a collaboration of population-based birth, childhood and 
adolescent cohorts including the cohorts participating in 
CAPICE. These cohorts are mainly based in Western Europe 
and Australia as, to our knowledge, no comparable cohorts 
exist in other countries. If there are, they are very welcome 
to participate.
Efforts to prevent and treat childhood psychopathology 
need to be informed by a clear understanding of the aetiology 
of mental disorders, and factors that impact the development 
of a chronic course. Due to the genetically informative, lon-
gitudinal designs of the eight included cohorts, CAPICE is 
well positioned to address questions regarding the interplay 
of genetic and environmental factors in the development, 
course, and comorbidity patterns of child psychiatric condi-
tions. Since CAPICE is an international training network, 
the analyses have been performed by 12 early stage research-
ers under the supervision of senior researchers at academic 
and non-academic sites across 5 European countries (Italy, 
The Netherlands, Norway, Sweden, and the United King-
dom). In this paper, we describe the six CAPICE objectives, 
as well as the methodological approaches that have been 
used and the initial results. The overview of the CAPICE 
research programme is illustrated in Fig. 1.
Objectives
(1) Elucidate the role of genetic and environmental fac-
tors in mental health symptoms across childhood and 
adolescence, and to establish the overlap in genetic risk 
factors with other traits related to childhood mental 
health symptoms.
  The projects that are part of this objective focus on 
the investigation of the overlap in genetic risk across 
phenotypes and ages, to explain comorbidity and per-
sistence, respectively. Moreover, analyses will focus 
on disentangling the role of genetic and environmental 
factors in associations between childhood mental health 
symptoms and parental phenotypes or risk factors early 
in life.
  Previous research suggests that both genetic and 
non-genetic factors play a role in the development and 
persistence of mental health symptoms and disorders. 
Depending on age, gender, and type of mental health 
symptoms, genetic factors explain between 40 and 80% 
of their symptom variance between individuals [5], 
indicating that the contributions of genetic and envi-
ronmental factors vary across disorders. Identifying 
mechanisms that underlie the persistence of symptoms 
and patterns of comorbidity are of specific importance 
in childhood psychopathology due to the potential 
impact of these disorders throughout the life course. 
Epidemiological studies have shown that about 50% of 
children with mental disorders still suffer from mental 
disorders in adulthood [6], including severe mental ill-
nesses such as schizophrenia (SCZ) [7]. As comorbid-
ity has been associated with worse prognosis [6, 8], it 
is essential to comprehend the mechanisms behind this.
  It is also still unknown to what extent the associa-
tions between environmental factors and mental dis-
orders are explained by causal processes, in which the 
environmental risk factor directly increases the risk 
for psychopathology, or by other processes such as, 
for example, gene–environment correlation, where the 
same genetic variants that influence a child’s risk for a 
mental disorder are associated with the child’s risk to 
be exposed to an unfavourable environment.
(2) Identify genetic, epigenetic, and transcriptomic variants 
associated with mental health symptoms during child-
hood and adolescence.
  There has been considerable progress in the field of 
psychiatric genetics with over two hundred genomic 
regions significantly associated with SCZ [9], bipo-
lar disorder (BD) [10], depression [11, 12], atten-
tion-deficit/hyperactivity disorder (ADHD) [13], and 
autism spectrum disorder (ASD) [14]. This has been 
achieved by large international collaborations such as 
the Psychiatric Genomics Consortium (PGC), perform-
ing meta-analyses with total sample sizes even up to 
100,000 subjects [12]. The number of variants which 
have been associated with childhood psychopathology 
at genome-wide significance is still lower than for adult 
mental disorders [13, 14], but polygenic analyses have 
suggested that genetic variation in childhood mental 
disorders, as in adult disorders, is primarily due to 
many genetic variants of small effect [15]. This would 
mean that genome-wide association studies (GWAS) 
of child and adolescent psychopathology, which so far 
have been notably smaller than the large meta-analyses 
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Table 1  General descriptions of the CAPICE cohorts
Cohort name Descriptions
ALSPAC The Avon Longitudinal Study of Parents and Children (ALSPAC) is a longitudinal pregnancy cohort which aimed to recruit all 
pregnant women in the former county of Avon with an expected due date between April 1991 and December 1992. Detailed 
information has continued to be collected on mothers, partners and children from 15,454 pregnancies in the cohort, this process 
has been described in detail elsewhere. Ethics approval for the study was obtained from the ALSPAC Ethics and Law Commit-
tee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was 
obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time. Consent 
for biological samples has been collected in accordance with the Human Tissue Act (2004). Please note that the study website 
contains details of all the data that is available through a fully searchable data dictionary and variable search tool: http://www.
brist ol.ac.uk/alspa c/resea rcher s/our-data/
TEDS The Twins Early Development Study (TEDS) is a longitudinal twin study that recruited over 16 000 twin pairs born between 1994 
and 1996 in England and Wales through national birth records. More than 10 000 of these families are still involved in the study. 
TEDS is a representative sample of the population in England and Wales. Rich cognitive and behavioural data have been col-
lected from the twins from infancy to emerging adulthood with data collection at ages 2, 3, 4, 7, 8, 9, 10, 12, 14, 16, 18, 19 and 
21, enabling longitudinal genetically sensitive study designs. Data have been collected from twins themselves (including exten-
sive web-based cognitive testing), from their parents and teachers, and from the UK National Pupil Database. More information 
may be found at: https ://www.teds.ac.uk/. Ethical approval for TEDS has been provided by the King’s College London Ethics 
Committee (Reference number: PNM/09/10-104). Parental consent was obtained before data collection
GenR The Generation R (Gen-R) study is a prospective cohort study from fetal life onwards that included pregnant women living in 
Rotterdam, the Netherlands, with an expected delivery date between April 2002 and January 2006 (n = 9778). The main aim 
of this study is to identify early environmental and genetic factors that affect growth, health and development. The Generation 
R Study is multidisciplinary and both prenatal and postnatal measures have included multiple domains of growth, health and 
development. Rotterdam is an ethnically diverse city and this is reflected in the Generation R participants. Of the enrolled moth-
ers, 42% was of non-Dutch ethnic background, largely made by mothers from Surinamese (9%), Turkish (7%) and Moroccan 
(3%) background. Data has been collected in children up until the mean age of 10 years, with current on-going data collection at 
mean age 13 years. Study protocols were approved by the local ethics committee, and written informed consent and assent was 
obtained from all parents and children. More information may be found at: https ://gener ation r.nl/resea rcher s/
NTR The Netherlands Twin Register (NTR) is a population-based prospective cohort study which includes new-born twins and multi-
ples from the Netherlands. Recruitment started with birth year 1986. NTR data collection has a focus on growth, development, 
emotional and behavioural problems and health. Phenotype data on emotional and behavioural problems were collected by 
surveys, in which parents and teachers were asked to rate their offspring/pupils’ behaviour using standardized instruments. At 
age 14 years and after, twins and their siblings were asked for self-assessments. Buccal cells and blood for DNA isolation were 
collected in multiple sub-projects. More information may be found at: https ://tweel ingen regis ter.vu.nl/. The study was approved 
by the Central Ethics Committee on Research Involving Human Subjects of the VU University Medical Centre, Amsterdam, 
an Institutional Review Board certified by the U.S. Office of Human Research Protections (IRB number IRB00002991 under 
Federal-wide Assurance- FWA00017598; IRB/institute codes, NTR 03-180)
TCHAD The Swedish Twin study of CHild and Adolescent Development (TCHAD) is a longitudinal study of how genes and environ-
ments contribute to the development of health and behavioural problems from childhood to adulthood. The study includes 1480 
twin pairs followed since 1994, when the twins were 8–9 years old. The last data collection was in 2005 when the twins were 
19–20 years old. Both parents and twins have provided data. More information may be found at: https ://ki.se/en/meb/twin-study 
-of-child -and-adole scent -devel opmen t-tchad . All responding parents, legal guardians or twins provided informed consent; 
digitally, written or by participation, to the study, and all data were deidentified. This study received ethical approval from the 
Karolinska Institutet Ethical Review Board
NFBC’86 Northern Finland Birth Cohort 1986 (NFBC1986) is a prospective longitudinal birth cohort which included pregnant women with 
expected date of delivery between July 1985 and June 1986 in the two Northern most provinces of Finland. In total, 9432 chil-
dren were live-born in the cohort. At approximately age 16 years, the cohort members were asked to complete a postal question-
naire, including the Youth Self-Report (YSR). At age 16 years blood samples taken for DNA extraction for 6 266 adolescents 
attending the clinical examination. All participants and their parents provided consent to use their data and received Institutional 
Review Board approval by the University of Oulu, and the Ethics committee of the Ostrobotnia Hospital district. More informa-
tion may be found at: https ://www.oulu.fi/nfbc/
CATSS The Child and Adolescent Twin Study in Sweden (CATSS) is an ongoing longitudinal twin study targeting all twins born in 
Sweden since July 1, 1992. Parents of twins are interviewed regarding the children’s somatic and mental health and social envi-
ronment in connection with their 9th or 12th birthdays and followed up over time. Follow-ups were conducted when the twins 
were 15 years of age and 18 years of age. All responding parents, legal guardians or twins provided informed consent; digitally, 
written or by participation, to the study, and all data were deidentified. This study received ethical approval from the Karolin-
ska Institutet Ethical Review Board. DNA samples (from saliva) were obtained from the participants at study enrolment. More 
information may be found at: https ://ki.se/en/meb/the-child -and-adole scent -twin-study -in-swede n-catss 
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above, have likely been underpowered. By increasing 
the sample size and performing meta-analyses across 
the EAGLE cohorts, including the CAPICE cohorts, 
it may be possible to detect genome-wide significant 
associations.
  In addition, because extended longitudinal data on 
mental health problems are available, it is possible 
to test whether genetic variants exert their influence 
across the lifespan or if their effect is restricted to a 
certain age period.
  Finally, as previous work has also suggested that 
the impact of environmental factors on childhood psy-
chopathology may be mediated by epigenetic varia-
tion (functional alterations in the genome that do not 
Table 1  (continued)
Cohort name Descriptions
MOBA The Norwegian Mother, Father and Child Cohort Study (MoBa) is a population-based pregnancy cohort study conducted by 
the Norwegian Institute of Public Health. Participants were recruited from all over Norway from 1999 to 2008. The women 
consented to participation in 41% of the pregnancies. The cohort now includes 114,500 children, 95,200 mothers and 75,200 
fathers. Parent and infant DNA samples were collected at birth and stored in a biobank. The establishment of MoBa and initial 
data collection was based on a license from the Norwegian Data protection agency and approval from The Regional Committees 
for Medical and Health Research Ethics. The MoBa cohort is based on regulations based on the Norwegian Health Registry Act. 
The current study was approved by The Regional Committees for Medical and Health Research Ethics (REK 2013/863). More 
information may be found at: https ://www.fhi.no/en/studi es/moba/
Table 2  Summary of available 
data in the CAPICE cohorts: 
number of children with 
survey data and genome-wide 
association data (N GWA) 
and epigenetics data (N epi) 
at ages 3–5 years, 6–8 years, 
9–11 years, 12–13 years, 
14–15 years, and 16–18 years
The first rows summarize the cohorts that assessed mental health symptoms either with the strengths and 
difficulties questionnaire (S) or the Achenbach system of empirically based assessment (A), the following 
row the cohorts with S and A measures, and the final rows the cohorts with other (O) measures
* Number of twins. O** A-TAC: Autism–Tics, AD/HD and other Comorbidities inventory, O***SCARED: 
screen for child anxiety related emotional disorders, MFQ: mood and feelings questionnaire
Cohort N GWA N epi 3–5 6–8 9–11 12–13 14–15 16–18
ALSPAC 8237 1018 S S S S S
TEDS* 10,346 S S S S S
GenR 2211 1500 A A A A
NTR* 6400 1400 A A A A A A
TCHAD* 1120 A A A
NFBC’86 4000 530 S A
CATSS* 11,400 O** O** S
MOBA 90,000 A O***
Overall total 73,714 4448
Fig. 1  Overview of the CAPICE 
research programme: the aims 
are to investigate the influence 
of genetic, epigenetic, and tran-
scriptomic variants on mental 
health symptoms, the interplay 
with the environment, and how 
these influences depend on age. 
Ultimately, these results will be 
integrated into a model predict-
ing the persistence of symptoms
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involve a change to DNA sequence [16]), identification 
of epigenetic differences associated to childhood men-
tal disorders is also part of this objective.
(3) Identify biological pathways associated with mental 
health symptoms and to validate potential drug targets 
based on these pathways.
  The current identified genetic variants (SNPs) for 
psychiatric disorders only explain a small part of 
their variance [17–19]. However, the joint effect of all 
tested variants explains on average around 30% of the 
variance of psychiatric disorders [20], which makes 
it worth to investigate these variants further [21]. A 
key step in the pathway from variant identification in 
GWAS to the development of potential treatment or 
prevention approaches is the characterization of bio-
logic pathways by which genetic variants affect dis-
orders. For instance, follow-up analyses can specify 
whether associated variants are involved in the same 
biological pathways, which then can offer leads to 
novel drug targets or the repurposing of existing drugs 
that were initially developed for the treatment of other 
diseases [21–23].
  In a recent study [22], a framework for drug repo-
sitioning is offered by associating transcriptomes 
imputed from GWAS data with drug-induced gene 
expression profiles from the Connectivity Map data-
base. When applied to mental disorders, the method 
identified many candidates for repositioning, several 
upheld by preclinical or clinical evidence as they 
included known psychiatric medications or therapies 
considered in clinical trials [22]. Validation studies of 
these approaches have recognized antipsychotics as 
potential drug targets for mental disorders, confirming 
the approach may be a productive technique for devel-
oping drug therapies for childhood psychiatric condi-
tions [24].
(4) Build a prediction model that identifies children at the 
highest risk of developing chronic mental health symp-
toms.
  To be able to provide treatment that takes into 
account the risk for persistence of symptoms, it is nec-
essary to build a prediction model that supports strati-
fying children into groups at high and low risk for a 
severe, chronic symptom course. Similar risk calcula-
tors based on clinical symptoms and cognitive profiles 
have already been established for high-risk individuals 
for SCZ or BD [25–27]. Including environmental fac-
tors and multi-omic biomarkers may further improve 
the performance of the model [28].
(5) Develop a sustainable international network of 
researchers in which collaboration is facilitated by data 
harmonization and information technology (IT) solu-
tions enabling a joint analysis of data over cohorts.
  The eight cohorts involved in CAPICE contain a 
wealth of data on childhood and adolescent mental 
health, but measures used to assess these traits dif-
fer across cohorts (see Table 2). One way to improve 
the power of studies combining results from multi-
ple cohorts is to use common units of measurement. 
Using item-response theory (IRT) based test linking 
in these cohorts; it is possible to evaluate the extent 
to which dimensions from the individual instruments 
can be mapped onto dimensions that are shared across 
instruments. Such an analysis was successfully applied 
earlier to measures of personality [29].
(6) Build a structure to disseminate the results to a broad 
audience of scientists, clinicians, patients and their par-
ents, and the general public.
  A limitation of research projects consists in the dif-
ficulty of properly disseminating their results, even if 
clinically relevant. Previous work has suggested that, 
even in targeted clinical research, it takes 17 years for 
14% of discovery research to be integrated into physi-
cian practice [30]. Etiological research on mental dis-
orders may include even broader dissemination gaps. 
To address this issue, CAPICE specifically aims to cre-
ate structures allowing for the dissemination of project 
results to a broad audience, for instance, through a web-
site and social network channels.
Methodology and results
Cohorts description
Before describing the approaches and results of each objec-
tive, we provide a general summary of the data collection of 
the eight CAPICE cohorts (see Tables 1, 2). All longitudinal 
cohorts have started either at birth or in childhood and use 
quantitative measures of psychopathology. These measures 
have been associated with clinical diagnoses [31–34] and are 
therefore widely used in clinical practice. The advantage of 
these dimensional measures is that they capture more of the 
variation present in the common population than dichoto-
mous measures that only specify the presence or absence of 
a diagnosis. For genome-wide SNP data, methods to impute 
the genotypes are widely available allowing for the same 
genetic variants to be analysed over cohorts. All cohorts 
have been described in more detail elsewhere: ALSPAC 
[35–37], TEDS [38], GenR [39, 40], NTR [41–43], TCHAD 
[44], NFBC’86 [45], CATSS [46, 47], MOBA [48]. For a 
link to cohort-specific websites and for a detailed description 
of the cohorts (see Table 1). All data used for the analyses 
were collected under protocols that have been approved by 
the appropriate ethics committees, and studies were per-
formed in accordance with the ethical standards.
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Objective 1: Elucidate the role of genetic and environ-
mental factors in mental health symptoms across childhood 
and adolescence, and to establish the overlap in genetic risk 
factors with other traits related to childhood mental health 
symptoms.
We refer to several excellent overviews for a description 
of the methods that can be used in genetic epidemiological 
studies analysing twin/family data and/or molecular genetic 
data [15, 49, 50]. In short, twin and family studies estimate 
the proportion of variance in a trait attributable to genetic 
and environmental factors by comparing the resemblance 
between pairs of relatives that differ in their relatedness. 
For example, if monozygotic twins, who are essentially 
100% genetically identical, are more alike than dizygotic 
twins, who share on average 50% of their co-segregating 
alleles, this is an indication that genetic factors play a role 
in explaining differences between individuals for a certain 
trait. This model can be extended to include other family 
members, to longitudinal or multivariate designs, and to 
study gene–environment interaction (G × E), even without 
a direct measure of the environment [51–53].
It is also possible to address these questions using geno-
typic data obtained for GWAS. In GWAS, common single 
nucleotide polymorphisms (SNPs) (positions in the DNA 
sequence that vary between individuals) measured across 
the whole genome are tested for their association with a trait. 
Many complex traits, like mental disorders, are influenced 
by multiple genetic loci. In this case, polygenic analyses, 
taking into account many SNPs, can be applied to investigate 
the cumulative impact of these SNPs on a trait, as well as on 
the co-occurrence of phenotypes or the persistence of symp-
toms over time [15, 49]. To this point, CAPICE researchers 
have performed twin and polygenic risk score analyses of 
the correlation between common mental health symptoms, 
such as internalizing problems and ADHD problems, and the 
stability of symptoms over time, including into adulthood.
Regarding the co-occurrence of symptoms, the covari-
ance could be explained by one common factor, the so-
called p-factor, which was found to be for 50–60% heritable. 
Moreover, genetic factors explained stability in this factor 
across ages. A polygenic p-factor risk score based on adult 
psychiatric disorders was also associated with the childhood 
p-factor [54].
The genetic association between adult psychiatric disor-
ders and childhood and adolescents traits was further inves-
tigated with polygenic analyses. The PGS for adult depres-
sion, neuroticism, BMI, and insomnia were significantly 
positively associated with childhood ADHD, internalizing 
and social problems, while the PGS for subjective well-being 
and educational attainment showed negative associations 
[55]. Only bipolar disorder PGS did not yield any significant 
associations. Effect sizes were in general similar across age 
and phenotype, although the PGS for educational attainment 
was more strongly associated with ADHD and the BMI PGS 
with ADHD and social problems [55]. A follow-up study is 
currently on the way, performing multivariate analyses to 
shed more light on the pattern of associations (https ://osf.
io/7nkw8 ).
Genetic data can also be leveraged to estimate the average 
causal effect of specific environmental factors, such as peri-
natal factors, on child or adolescent psychopathology, using 
a method known as Mendelian randomization (MR). Sev-
eral ongoing CAPICE projects have applied this approach to 
estimate the effect of prenatal risk factors, such as maternal 
smoking, on childhood mental health problems. It is impor-
tant to recognize that the assumptions that are required for 
MR may not hold for all prenatal exposures and offspring 
outcomes [56]. Therefore, methods to identify violations of 
the MR assumptions are also evaluated and approaches that 
require fewer assumptions are tested.
Another method to analyse the mechanisms underlying 
parent-offspring associations is maternal genome-wide com-
plex trait analysis (M-GCTA), which can be applied when 
parental genotypic data are also available. M-GCTA can be 
used to calculate whether the association between parent and 
offspring psychopathology is explained by an environmental 
effect on top of the effect of the genetic transmission [57]. 
Applying this method to the MoBa data indicated no such 
effects for anxiety and depression at age 8 [58]. Analyses on 
a larger so more powerful sample and including external-
izing problems are currently performed.
Objective 2: Identify genetic, epigenetic, and transcrip-
tomic variants associated with mental health symptoms dur-
ing childhood and adolescence.
GWAS have provided insight into the genetic basis of 
quantitative variation in complex traits in the past decade 
[20]. By increasing the sample size and performing meta-
analyses across the EAGLE cohorts, including the CAPICE 
cohorts, it may be possible to detect genome-wide signifi-
cant associations and to detect age effects. A large-scale 
GWAMA using a multivariate method to analyse summary 
statistics that are not independent [59] focused on identi-
fying genetic variants that influence the development and 
course of internalising symptoms from ages 3 to 18 (https 
://osf.io/w5adg /). Three gene-wide significant effects were 
detected as well as significant genetic associations with adult 
depression and related traits as well as with childhood traits. 
Another study explores the effect of (ultra) rare and common 
variation in genes specific to brain cell types on neuropsy-
chiatric disorders (https ://osf.io/uyv2s ).
Previous work has also suggested that the impact of 
environmental factors on childhood psychopathology 
may be mediated by epigenetic variation, which consists 
of functional alterations in the genome that do not involve 
a change to DNA sequence [16]. While there are several 
forms of epigenetic variation, most epigenetic studies have 
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focused on alterations in DNA methylation. Epigenome-
wide association studies (EWAS) are performed to test the 
effect of maternal mid-pregnancy vitamin D on offspring 
cord blood methylation and of the association between 
variation in child peripheral and cord blood methylation 
and the subsequent development of ADHD.
Under very strong assumptions, mediation of the possi-
ble average causal effect of prenatal exposures on offspring 
psychiatric outcomes might be tested using an extension 
of the MR approach, incorporating genetic variants as pro-
posed instruments for a particular prenatal exposure and 
for methylation at a specific locus. In certain contexts, this 
might be considered as a follow up to the present studies.
The association of prenatal maternal smoking with 
offspring blood DNA methylation has been investigated 
in individuals aged 16–48 years, and MR and mediation 
analyses have been performed to evaluate whether meth-
ylation markers have causal effects on disease outcomes 
in the offspring [60]. 69 differentially methylated CpGs in 
36 genomic regions (P-value < 1 × 10−7) were found to be 
associated with exposure to maternal smoking in adoles-
cents and adults and MR analyses delivered evidence for a 
causal role of four maternal smoking-related CpG sites on 
an increased risk of SCZ or inflammatory bowel disease 
[60]. Further studies analyse whether alcohol, tobacco, 
and caffeine use in pregnancy might be causally related 
to ADHD in the offspring using negative control and MR 
approaches (https ://osf.io/wxu58 ) (https ://osf.io/aqrxp ).
Objective 3: Identify biological pathways associated 
with mental health symptoms and to validate potential 
drug targets based on these pathways.
Applying drug pathway analyses to the CAPICE GWAS 
results may permit us to derive hypotheses about potential 
drug targets and consequently possibilities for drug repur-
posing. The GWAMA on internalizing problems did not 
detect biological pathways (https ://osf.io/w5adg /) so could 
not identify drug targets. This is not surprising as there 
were not many significantly associated genes.
Objective 4: Build a prediction model that identifies 
children at the highest risk of developing chronic mental 
health symptoms.
Using cohort data, as well as Swedish registry data, 
studies have been performed to predict outcomes of psy-
chiatric symptoms in childhood and adolescence, focusing 
not only on mental disorders but also on somatic medical 
outcomes. As part of these analyses, a machine learning 
model including 474 predictors has been developed that 
can predict mental health problems in adolescence using 
data from the Child and Adolescent Twin Study in Sweden 
(CATSS) [61]. The suggested model would not be appro-
priate for medical purposes, but it helps to build better 
models to predict mental health outcomes [61].
Moreover, longitudinal analyses of data from the Swedish 
and Dutch twin registers indicated that adolescent anxiety is 
associated with psychiatric disorders later in life, even when 
adjusting for other mental health issues [62].
Objective 5: Develop a sustainable international network of 
researchers in which collaboration is facilitated by data harmo-
nization and information technology (IT) solutions enabling a 
joint analysis of data over cohorts.
Using Item-Response Theory (IRT) based test linking it has 
been evaluated whether internalizing and ADHD symptoms 
assessed by different instruments can be mapped onto dimen-
sions that are shared across instruments. These analyses were 
possible as some of the EAGLE cohorts (ABCD [63], Raine 
[64], and TEDS [38]), had measured mental health symptoms 
of the same individuals at the same age with two or more 
instruments. This could allow combining individual raw item 
data from different instruments to maximize statistical power.
In addition, to facilitate data analyses over cohorts, a 
searchable data catalogue is created. The variables important 
for the current project include demographic and family char-
acteristics, individual’s school achievements, mental health 
measures (both psychopathology as well as wellbeing) by 
various raters (mother, father, self-report, teacher), preg-
nancy/perinatal measures, several general health and anthro-
pometric measures, parenting, parental mental health, and 
several genomic measures and biomarkers in children and 
parents. To build a search engine that returns items including 
the searched term as well as related terms, text mining of 
available data documentation has been used to identify rela-
tionships between words. These results can then be used to 
develop an advanced search engine for the data catalogue. If 
“mental health” is, for example, the search term, the results 
will also include “emotional problems”, “behavioural prob-
lems”, and “psychiatric history of the mother”.
Objective 6: Build a structure to disseminate the results to 
a broad audience of scientists, clinicians, patients and their 
parents, and the general public.
To engage the general public with the results from these 
studies, CAPICE researchers have also created content 
designed for a lay audience on the website (http://www.capic 
e-proje ct.eu/index ), Twitter (https ://twitt er.com/capic e_proje 
ct), YouTube (https ://www.youtu be.com/chann el/UCgq8 
uIHiH E69Il cHoYC jwKg/featu red?view_as=subsc riber ), 
LinkedIn and Facebook. CAPICE was also represented at 
the Greenman Festival in Wales, UK, and ESRs presented 
multiple times on several international conferences.
Discussion
Genetic research, including psychiatric genetics, has sub-
stantially moved forward due to large-scale collaborations in 
consortia, with meta-analyses being the rule rather than the 
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exception. Due to developments in methodology, it is also 
possible to use the genome-wide genotypic data for purposes 
other than the identification of genetic risk variants. Given 
the small effect sizes, these analyses need large samples 
to achieve adequate statistical power. The cohorts brought 
together in CAPICE and the close collaboration with the 
EAGLE behavior and cognition group (https ://www.eagle 
-conso rtium .org/) has provided an opportunity to perform 
these analyses and progress the field of child psychiatry by 
addressing essential questions like “Which genetic variants 
and biological pathways underlie the continuity of symptoms 
from childhood into adulthood?”; “Which factors explain 
the associations of childhood psychopathology with early 
life and familial risk factors?”; “What is the role of epige-
netic factors in the development of the child and adolescent 
psychopathology?”; “Can we predict which children are at 
higher risk for poorer outcomes?”.
The ultimate aim is that these results will inform the 
development of future treatment and prevention efforts, 
including supporting the identification of novel targets for 
existing pharmacological agents. Moreover, having bet-
ter prediction tools will bring precision medicine closer 
for child psychiatry as it provides the opportunity to test 
interventions specifically targeted at children at high or at 
low risk for the persistence of symptoms.
We acknowledge that the studies performed in the frame-
work of CAPICE are largely restricted to children and fami-
lies with a Western European genetic ancestry. Extending 
genetic data collection to children and families from other 
backgrounds is essential to gain knowledge on similarities 
and differences between groups from various backgrounds.
These analyses have all been performed as part of a 
training program for Early Stage Researchers. These 
researchers receive not only mentoring from senior aca-
demics on their specific projects but also a structured cur-
riculum of workshops on child psychiatry, statistics, and 
dissemination strategy throughout the grant period. These 
workshops as well as the secondments at other participat-
ing institutions aim to build a new generation of creative 
and innovative researchers who might exert a relevant 
impact on academic and non-academic organizations.
In conclusion, CAPICE provides a broad package of 
training in the field of psychiatric genetics, going from 
harmonizing the phenotypes, the creation of facilities for 
analyses across cohorts and the actual state-of-the-art 
analyses, to the translation of the results for drug target 
validation or prediction models that can be used in the 
clinic for targeted interventions.
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